drug costs

1:56PM
Printer-friendly version
Ottawa’s revisions to drug-pricing review board will delay or prevent access to new drugs

Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.


12:00PM
Printer-friendly version
Last week, to great fanfare and much media attention across the country, the Canadian Medical Association Journal announced the publication of a new study trumpeting the great benefits Canada would accrue by going ahead with national government funded pharmaceutical drug coverage.